Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

395 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Ketanserin and alpha 1-adrenergic antagonism in humans.
Zabludowski JR, Ball SG, Robertson JI. Zabludowski JR, et al. Among authors: robertson ji. J Cardiovasc Pharmacol. 1985;7 Suppl 7:S123-5. doi: 10.1097/00005344-198500077-00036. J Cardiovasc Pharmacol. 1985. PMID: 2412032 Clinical Trial.
Effect of the 5-hydroxytryptamine type 2 receptor antagonist, ketanserin, on blood pressure, the renin-angiotensin system and sympatho-adrenal function in patients with essential hypertension.
Zabludowski JR, Zoccali C, Isles CG, Murray GD, Robertson JI, Inglis GC, Fraser R, Ball SG. Zabludowski JR, et al. Among authors: robertson ji. Br J Clin Pharmacol. 1984 Mar;17(3):309-16. doi: 10.1111/j.1365-2125.1984.tb02346.x. Br J Clin Pharmacol. 1984. PMID: 6712863 Free PMC article. Clinical Trial.
Antihypertensive mode of action of ketanserin.
Robertson JI, Stott DJ, Ball SG. Robertson JI, et al. J Cardiovasc Pharmacol. 1987;10 Suppl 3:S45-7. J Cardiovasc Pharmacol. 1987. PMID: 2446069 Review.
395 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page